List of methylphenidate analogues

File:Methylphenidate3Dan.gif

3D model of methylphenidate

The list of methylphenidate analogues includes a variety of chemical compounds that are structurally related to methylphenidate, a central nervous system stimulant commonly used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. These analogues have been developed to explore variations in pharmacological activity, potency, and therapeutic applications.

Structure and Function

Methylphenidate analogues share a common structural framework with methylphenidate, characterized by a piperidine ring. The general structure of these compounds can be modified at various positions to yield different analogues with potentially unique properties.

File:Phenidate general structure.png

General structure of phenidate analogues

The core structure of methylphenidate consists of a piperidine ring, a phenyl ring, and an ester linkage. Modifications to the phenyl ring, the ester group, or the piperidine ring can result in changes to the pharmacokinetics and pharmacodynamics of the compound.

Common Analogues

Several methylphenidate analogues have been synthesized and studied for their potential use in medicine or as research tools. Some of the notable analogues include:

Ethylphenidate

Ethylphenidate is an analogue where the methyl group of methylphenidate is replaced with an ethyl group. This compound has been studied for its effects on dopamine and norepinephrine reuptake inhibition.

Dexmethylphenidate

Dexmethylphenidate is the dextrorotatory enantiomer of methylphenidate. It is marketed under the brand name Focalin and is used in the treatment of ADHD.

Ritalinic Acid

File:Ritalinic acid-2D-skeletal.svg

Structure of ritalinic acid

Ritalinic acid is a primary metabolite of methylphenidate. It is formed by the hydrolysis of the ester linkage in methylphenidate, resulting in a carboxylic acid group.

Ritalinamide

File:Ritalinamide structure.png

Structure of ritalinamide

Ritalinamide is an amide derivative of ritalinic acid. It has been studied for its potential as a prodrug of methylphenidate.

Pharmacological Properties

Methylphenidate analogues generally act as dopamine reuptake inhibitors and norepinephrine reuptake inhibitors, similar to methylphenidate itself. The specific pharmacological profile of each analogue can vary based on its chemical structure, influencing its potency, duration of action, and side effect profile.

Research and Development

The development of methylphenidate analogues is driven by the need to find compounds with improved therapeutic profiles, reduced side effects, or novel applications. Research continues to explore the potential of these analogues in treating various neurological and psychiatric disorders.

Related Pages

• Methylphenidate
• Attention deficit hyperactivity disorder
• Dopamine reuptake inhibitor
• Norepinephrine reuptake inhibitor